Katia Youssov

819 total citations
33 papers, 379 citations indexed

About

Katia Youssov is a scholar working on Cellular and Molecular Neuroscience, Neurology and Molecular Biology. According to data from OpenAlex, Katia Youssov has authored 33 papers receiving a total of 379 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Cellular and Molecular Neuroscience, 24 papers in Neurology and 7 papers in Molecular Biology. Recurrent topics in Katia Youssov's work include Genetic Neurodegenerative Diseases (29 papers), Neurological disorders and treatments (21 papers) and Mitochondrial Function and Pathology (7 papers). Katia Youssov is often cited by papers focused on Genetic Neurodegenerative Diseases (29 papers), Neurological disorders and treatments (21 papers) and Mitochondrial Function and Pathology (7 papers). Katia Youssov collaborates with scholars based in France, Germany and Switzerland. Katia Youssov's co-authors include Anne‐Catherine Bachoud‐Lévi, Guillaume Dolbeau, Christophe Verny, Perrine Charles, Alexandra Dürr, Laurent Cléret de Langavant, Audrey Olivier, Patrick Maison, Ralf Reilmann and David Craufurd and has published in prestigious journals such as PLoS ONE, Brain and Neuropsychologia.

In The Last Decade

Katia Youssov

29 papers receiving 374 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Katia Youssov France 10 283 216 134 40 38 33 379
Jennifer L. Taylor United States 8 156 0.6× 178 0.8× 60 0.4× 50 1.3× 18 0.5× 10 364
Carla D’Ascenzo Italy 14 203 0.7× 321 1.5× 209 1.6× 19 0.5× 38 1.0× 22 532
Marcelo Miranda Chile 12 88 0.3× 114 0.5× 71 0.5× 59 1.5× 40 1.1× 35 313
Marta Manes Italy 11 99 0.3× 128 0.6× 78 0.6× 42 1.1× 47 1.2× 18 285
D. Monza Italy 11 261 0.9× 401 1.9× 117 0.9× 59 1.5× 57 1.5× 11 525
Andone Sistiaga Spain 10 160 0.6× 118 0.5× 111 0.8× 37 0.9× 32 0.8× 24 285
Elin M. Rees United Kingdom 10 256 0.9× 200 0.9× 111 0.8× 53 1.3× 25 0.7× 13 314
Tomás López‐Alburquerque Spain 14 104 0.4× 221 1.0× 51 0.4× 30 0.8× 18 0.5× 27 387
Sean Rogers United States 5 92 0.3× 145 0.7× 57 0.4× 120 3.0× 89 2.3× 10 361
Hanna Iderberg Sweden 10 347 1.2× 247 1.1× 115 0.9× 58 1.4× 16 0.4× 11 468

Countries citing papers authored by Katia Youssov

Since Specialization
Citations

This map shows the geographic impact of Katia Youssov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katia Youssov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katia Youssov more than expected).

Fields of papers citing papers by Katia Youssov

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katia Youssov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katia Youssov. The network helps show where Katia Youssov may publish in the future.

Co-authorship network of co-authors of Katia Youssov

This figure shows the co-authorship network connecting the top 25 collaborators of Katia Youssov. A scholar is included among the top collaborators of Katia Youssov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katia Youssov. Katia Youssov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Youssov, Katia, Étienne Audureau, Jean‐Philippe Azulay, et al.. (2025). Comparison of tetrabenazine, tiapride and olanzapine in Huntington's disease: a one-year French randomized multicenter study (Neuro-HD). Parkinsonism & Related Disorders. 140. 108017–108017.
2.
Langavant, Laurent Cléret de, Katia Youssov, Renaud Massart, et al.. (2024). The joint memory effect: challenging the selfish stigma in Huntington’s disease?. Brain Communications. 7(1). fcae440–fcae440.
3.
4.
Lunven, Marine, et al.. (2024). Cognitive reserve involves decision making and is associated with left parietal and hippocampal hypertrophy in neurodegeneration. Communications Biology. 7(1). 741–741. 3 indexed citations
5.
Youssov, Katia, et al.. (2023). Language disorders in patients with striatal lesions: Deciphering the role of the striatum in language performance. Cortex. 166. 91–106. 2 indexed citations
6.
Lunven, Marine, Katia Youssov, Blanche Bapst, et al.. (2023). A new approach to digitized cognitive monitoring: validity of the SelfCog in Huntington’s disease. Brain Communications. 5(2). fcad043–fcad043. 3 indexed citations
7.
Ortigoza‐Escobar, Juan Darío, Jean‐Marc Burgunder, Caterina Mariotti, et al.. (2022). Corrigendum: Combining Literature Review With a Ground Truth Approach for Diagnosing Huntington's Disease Phenocopy. Frontiers in Neurology. 13. 891800–891800. 1 indexed citations
8.
Youssov, Katia, Étienne Audureau, Richard Layese, et al.. (2022). The burden of Huntington's disease: A prospective longitudinal study of patient/caregiver pairs. Parkinsonism & Related Disorders. 103. 77–84. 8 indexed citations
9.
Lunven, Marine, Katia Youssov, Blanche Bapst, et al.. (2022). The striatum in time production: The model of Huntington's disease in longitudinal study. Neuropsychologia. 179. 108459–108459. 1 indexed citations
10.
Bayen, É., Laurent Cléret de Langavant, Katia Youssov, & Anne‐Catherine Bachoud‐Lévi. (2022). Informal care in Huntington's disease: Assessment of objective-subjective burden and its associated risk and protective factors. Annals of Physical and Rehabilitation Medicine. 66(4). 101703–101703. 3 indexed citations
11.
Ortigoza‐Escobar, Juan Darío, Jean‐Marc Burgunder, Caterina Mariotti, et al.. (2022). Combining Literature Review With a Ground Truth Approach for Diagnosing Huntington's Disease Phenocopy. Frontiers in Neurology. 13. 817753–817753. 5 indexed citations
12.
Lunven, Marine, et al.. (2022). Predicting clinical scores in Huntington’s disease: a lightweight speech test. Journal of Neurology. 269(9). 5008–5021. 10 indexed citations
13.
Lunven, Marine, Katia Youssov, Étienne Audureau, et al.. (2021). Cognitive decline in Huntington’s disease in the Digitalized Arithmetic Task (DAT). PLoS ONE. 16(8). e0253064–e0253064. 4 indexed citations
14.
Bachoud‐Lévi, Anne‐Catherine, Joaquim J. Ferreira, Renaud Massart, et al.. (2019). International Guidelines for the Treatment of Huntington's Disease. Frontiers in Neurology. 10. 710–710. 119 indexed citations
15.
Désaméricq, G., Katia Youssov, Perrine Charles, et al.. (2016). Guidelines for clinical pharmacological practices in Huntington's disease. Revue Neurologique. 172(8-9). 423–432. 5 indexed citations
16.
Désaméricq, G., Katia Youssov, Guillaume Dolbeau, et al.. (2016). Insulin-Like Growth Factor-1 but Not Insulin Predicts Cognitive Decline in Huntington’s Disease. PLoS ONE. 11(9). e0162890–e0162890. 9 indexed citations
17.
Schramm, Catherine, Sandrine Katsahian, Katia Youssov, et al.. (2015). How to Capitalize on the Retest Effect in Future Trials on Huntington’s Disease. PLoS ONE. 10(12). e0145842–e0145842. 8 indexed citations
18.
Langavant, Laurent Cléret de, Christophe Verny, Pierre Krystkowiak, et al.. (2015). Longitudinal Study of Informed Consent in Innovative Therapy Research: Experience and Provisional Recommendations from a Multicenter Trial of Intracerebral Grafting. PLoS ONE. 10(5). e0128209–e0128209. 8 indexed citations
19.
Diego‐Balaguer, Ruth de, Maryline Couette, Guillaume Dolbeau, et al.. (2008). Striatal degeneration impairs language learning: evidence from Huntington's disease. Brain. 131(11). 2870–2881. 48 indexed citations
20.
Jedynak, C P, Katia Youssov, Emmanuelle Apartis, et al.. (2008). Dystonies et tremblements d’utilisation instrumentale répétitive. Revue Neurologique. 164(1). 53–60. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jennifer L. Taylor Breakdown of academic impact, for papers by Carla D’Ascenzo Breakdown of academic impact, for papers by Marcelo Miranda Breakdown of academic impact, for papers by Marta Manes Breakdown of academic impact, for papers by D. Monza Breakdown of academic impact, for papers by Andone Sistiaga Breakdown of academic impact, for papers by Elin M. Rees Breakdown of academic impact, for papers by Tomás López‐Alburquerque Breakdown of academic impact, for papers by Sean Rogers Breakdown of academic impact, for papers by Hanna Iderberg
Rankless by CCL
2026